a transcription factor that plays a role in the inducible expression of cytokine genes in T cells, especially in the induction of the IL-2 and IL-4. Also control gene expression in embryonic cardiac cells. Could regulate not only the activation and proliferation but also the differentiation and programmed death of lymphoid and nonlymphoid cells. Highly expressed in placenta, lung, kidney, testis and ovary. Weakly expressed in spleen and thymus. Not expressed in peripheral blood lymphocytes. 23 alternatively spliced isoforms of the human protein hve been reported. Note: This description may include information from UniProtKB.
Biological Process: transcription from RNA polymerase II promoter; heart development; cellular respiration; muscle cell development; regulation of synaptic plasticity; negative regulation of dendrite morphogenesis; negative regulation of transcription from RNA polymerase II promoter; positive regulation of tumor necrosis factor production; patterning of blood vessels; calcineurin-NFAT signaling pathway; DNA damage response, signal transduction resulting in induction of apoptosis; positive regulation of transcription from RNA polymerase II promoter; smooth muscle cell differentiation; inflammatory response
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.